Apellis Pharmaceuticals, Inc.
2019 Q4 - 2025 Q2 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q2 | 8/14/2025 | 423 | 0.0% | 24,443 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 620 | 0.0% | 28,350 | 3/31/2025 |
| 2023 Q4 | 2/14/2024 | 2,358 | 0.1% | 39,392 | 12/31/2023 |
| 2023 Q1 | 5/15/2023 | 6 | 0.0% | 89 | 3/31/2023 |
| 2022 Q4 | 2/27/2023 | 1,649 | 0.0% | 31,880 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 5,269 | 0.1% | 77,153 | 9/30/2022 |
| 2022 Q2 | 8/17/2022 | 2,173 | 0.0% | 48,063 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 1 | 0.0% | 10 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 517 | 0.0% | 10,936 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 1 | 0.0% | 44 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 2,933 | 0.1% | 46,414 | 6/30/2021 |
| 2020 Q2 | 8/14/2020 | 13 | 0.0% | 393 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 386 | 0.0% | 14,396 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 69 | 0.0% | 2,244 | 12/31/2019 |